Activation of the cGAS-STING signaling pathway in adenomyosis patients

Yun Lin1, Luying Wang1, Mingzhu Ye1

  • 1Department of Obstetrics and Gynecology, The 3rd Xiangya Hospital of Central South University, Changsha, Hunan, China.

Abstract

Insights

The cyclic GMP-AMP synthase-stimulator of interferon genes (cGAS-STING) pathway is activated in adenomyosis, correlating with disease severity and symptoms like dysmenorrhea. This suggests the pathway plays a role in adenomyosis development.

Area of Science:

  • Gynecologic pathology
  • Immunology
  • Molecular biology

Background:

  • Adenomyosis is a condition where endometrial tissue implants within the uterine myometrium.
  • The role of innate immune pathways, such as the cGAS-STING pathway, in adenomyosis pathogenesis is not well understood.

Purpose of the Study:

  • To investigate the activation status of the cGAS-STING pathway in adenomyosis.
  • To explore the correlation between cGAS-STING pathway activation and clinical outcomes in adenomyosis patients.

Main Methods:

  • Quantitative real-time reverse-transcription polymerase chain reaction (qRT-PCR) and immunohistochemistry were used to measure mRNA and protein levels of cGAS-STING pathway components.
  • Tissue samples from adenomyosis patients and controls were analyzed.
  • Correlation analysis was performed between gene expression and clinical parameters like dysmenorrhea and uterine volume.

Main Results:

  • Significantly elevated mRNA and protein levels of cGAS, STING, TANK-binding kinase 1 (TBK-1), interferon-α (IFN-α), IFN-β, and tumor necrosis factor-α (TNF-α) were observed in adenomyosis tissues compared to controls.
  • cGAS and STING gene expression correlated with TBK-1, IFN-β, and TNF-α expression.
  • TBK-1 and TNF-α expression levels were significantly correlated with the severity of dysmenorrhea.

Conclusions:

  • The cGAS-STING pathway is activated in adenomyosis.
  • Pathway activation is linked to clinical manifestations, particularly dysmenorrhea.
  • The cGAS-STING pathway may be a key contributor to the pathogenesis of adenomyosis and a potential therapeutic target.

Related Concept Videos

GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
6.2K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
8.2K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
7.1K
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.5K
Intracellular Signaling Cascades01:24

Intracellular Signaling Cascades

Once a ligand binds to a receptor, the signal is transmitted through the membrane and into the cytoplasm. The continuation of a signal in this manner is called signal transduction. Signal transduction only occurs with cell-surface receptors, which cannot interact with most components of the cell, such as DNA. Only internal receptors can interact directly with DNA in the nucleus to initiate protein synthesis. When a ligand binds to its receptor, conformational changes occur that affect the...
49.6K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
14.7K